Related Experiment Video
Updated: Apr 10, 2026

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
Published on: February 28, 2013
Skewed Epigenetics: An Alternative Therapeutic Option for Diabetes Complications
Gabriele Togliatto1, Patrizia Dentelli1, Maria Felice Brizzi1
1Department of Medical Sciences, University of Turin, Corso Dogliotti 14, 10126 Turin, Italy.
Abstract:
Vascular complications are major causes of morbidity and mortality in type 2 diabetes patients. Mitochondrial reactive oxygen species (ROS) generation and a lack of efficient antioxidant machinery, a result of hyperglycaemia, mainly contribute to this problem. Although advances in therapy have significantly reduced both morbidity and mortality in diabetic individuals, diabetes-associated vascular complications are still one of the most challenging health problems worldwide. New healing options are urgently needed as current therapeutics are failing to improve long-term outcomes. Particular effort has recently been devoted to understanding the functional relationship between chromatin structure regulation and the persistent change in gene expression which is driven by hyperglycaemia and which accounts for long-lasting diabetic complications. A detailed investigation into epigenetic chromatin modifications in type 2 diabetes is underway. This will be particularly useful in the design of mechanism-based therapeutics which interfere with long-lasting activating epigenetics and improve patient outcomes. We herein provide an overview of the most relevant mechanisms that account for hyperglycaemia-induced changes in chromatin structure; the most relevant mechanism is called "metabolic memory."
Insights
Type 2 diabetes vascular complications stem from high blood sugar, causing oxidative stress. Understanding epigenetic changes, like metabolic memory, offers new therapeutic targets for long-term diabetic health.
Area of Science:
- Endocrinology and Metabolism
- Molecular Biology
- Genetics
Background:
- Vascular complications in type 2 diabetes (T2D) significantly increase morbidity and mortality.
- Hyperglycemia-induced mitochondrial reactive oxygen species (ROS) and impaired antioxidant defenses are key contributors.
- Current therapies improve outcomes but fail to fully address long-term vascular issues, necessitating novel approaches.
Purpose of the Study:
- To explore the link between chromatin structure regulation and persistent gene expression changes in T2D.
- To investigate epigenetic modifications in T2D for developing mechanism-based therapeutics.
- To provide an overview of hyperglycemia-induced chromatin structure alterations, focusing on metabolic memory.
Main Methods:
- Review of current literature on hyperglycemia, oxidative stress, and vascular complications in T2D.
- Analysis of research on epigenetic modifications, specifically chromatin structure.
- Focus on the 'metabolic memory' phenomenon as a key mechanism.
Main Results:
- Hyperglycemia drives persistent changes in gene expression through epigenetic modifications.
- These epigenetic alterations contribute to long-lasting diabetic vascular complications.
- Metabolic memory is identified as a primary mechanism linking hyperglycemia to sustained chromatin changes.
Conclusions:
- Epigenetic chromatin modifications are crucial in the pathogenesis of T2D vascular complications.
- Targeting these long-lasting epigenetic changes, particularly metabolic memory, holds promise for new therapeutic strategies.
- Further investigation into T2D epigenetics is essential for improving patient outcomes and developing effective treatments.
More Related Videos
08:45Epigenetic Conversion as a Safe and Simple Method to Obtain Insulin-secreting Cells from Adult Skin Fibroblasts
Published on: March 18, 2016
06:16White and Brown Adipose Grafts: An Approach to Correct Reproductive, Metabolic, and Renal Deficits in Black and Tan Brachyury (BTBR) Obese Mice
Published on: September 9, 2025
Related Concept Videos
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Diabetes Mellitus: Type 2 and Gestational
Psychoneuroimmunology: Diabetes and Cancer